An interventional study of Doing ICSI I a medium supplemented with Ionomycin and Latrunculin A in Infertility, sponsored by Ibn Sina Hospital. Completed at 3 sites in Egypt. Open to female participants aged 18 Years to 42 Years. Per ClinicalTrials.gov, last updated 2019-05-07.
Sponsored by Ibn Sina Hospital · Not applicable, Interventional, and Other
Using Latrunculin A and Ionomycin would improve the outcome of ICSI if the handling medium during the ICSI procedure has them.
2,506 studies on the registry are indexed under Infertility; 407 are open to participants now.
This study's enrollment of 700 is above the median of 120 across 1,698 interventional studies indexed under Infertility.
Browse Infertility studies →Ibn Sina Hospital is the lead sponsor of 28 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
-
Other: Doing ICSI I a medium supplemented with Ionomycin and Latrunculin A
Ionomycin and Latrunculin A would activate oocyte during ICSI along with cytoskeleton stabilization for a favourable outcomes
Fertilization rate
Time frame: 6 days of culture
Rates of Blastocyst formation and quality
Number of formed blastocysts and blastocysts with good-quality per fertilized oocytes
Time frame: 6 days of culture
embryo utilization rate
Time frame: 6 days of culture
clinical pregnancy rate
Time frame: three months
ongoing pregnancy rate
Time frame: 12 weeks
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in May 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ibn Sina Hospital